1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
LAMEA Cancer Immunotherapy MarketAnalysis (2017-2023)

LAMEA Cancer Immunotherapy MarketAnalysis (2017-2023)

  • December 2017
  • 84 pages
  • ID: 5304193

Summary

Table of Contents

The LAMEA Cancer Immunotherapy Market would witness market growth of 17.9% CAGR during the forecast period (2017 – 2023). Cancer immunotherapy is the type of cancer treatment helping the immune system fight cancer.

There are various kinds of cancer immunotherapies used and they are monoclonal antibody, therapeutic cancer vaccines, checkpoint inhibitors, cytokines, and others. Growing patient population that is suffering from different types of cancer such as lung cancer, breast cancer, ovarian cancer, and other cancers are the factors that drive the global cancer immunotherapy market. Additionally, growing geriatric population and governmental contribution to healthcare expenditure are some other factors that add to the market growth.

The key factors driving the growth of cancer immunotherapy market are rising incidence and prevalence of cancer, technologically advanced treatment therapies, Growing R&D activities to treat cancer, and specificity & effectiveness of cancer immunotherapy for the treatment of wide range of cancers such as lung cancer, breast cancer, skin cancer, and others. Also, growing healthcare expenditure and better healthcare insurance coverage would further add to the market growth during the analysis period. Nevertheless, lack of professional healthcare experts and limited awareness about possible solutions among the population are the factors that limit the growth.

Based on Technology, the market report segments the market into Monoclonal Antibodies, Cytokines & Immunomodulators, and Other Technology. End user is segmented into Polymeric Coatings and Organic Coatings.

The Application covered under the report includes Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head & Neck Cancer, and Other Cancer. The report also covers geographical segmentation of Cancer Immunotherapy market. The report also covers country wise segmentation of Cancer Immunotherapy market. The countries included in the report are Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the LAMEA Cancer Immunotherapy Market. Key companies profiled in the report include Novartis Ag, Astrazeneca Plc., Amgen Inc., Immunomedics, Inc., Bayer Ag, Pfizer Inc., Bristol-Myers Squibb, Merck Sharp & Dohme Corp., Eli Lilly And Company, and F. Hoffmann-La Roche Ltd.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Nicolas helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Cancer Vaccines: Analytical Tool

Cancer Vaccines: Analytical Tool

  • $ 3950
  • November 2018

With the first prophylactic cancer vaccine Gardasil approved in 2006 and therapeutic cancer vaccine Sipuleucel-T (Provenge) approved in 2010, cancer vaccines is a proven hot treatment modality which is ...

Clinical Research in Vulvar Cancer in H2, 2018

Clinical Research in Vulvar Cancer in H2, 2018

  • $ 2500
  • September 2018

Vulvar Cancer Global Clinical Trials Review, H2, 2018SummaryGlobalData’s clinical trial report, “Vulvar Cancer Global Clinical Trials Review, H2, 2018" provides an overview of Vulvar Cancer clinical ...

Clinical Research in Squamous Non-Small Cell Lung Cancer in H2, 2018

Clinical Research in Squamous Non-Small Cell Lung Cancer in H2, 2018

  • $ 2500
  • August 2018

Squamous Non-Small Cell Lung Cancer Global Clinical Trials Review, H2, 2018SummaryGlobalData’s clinical trial report, “Squamous Non-Small Cell Lung Cancer Global Clinical Trials Review, H2, 2018" provides ...


ref:plp2017

Reportlinker.com © Copyright 2018. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on